Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Income Statement

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Income Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
INCOME :
Gross Sales ₹10,677 Cr₹910,563 Cr₹8,071 Cr₹647 Cr₹61,007 Cr
     Sales ₹10,607 Cr₹904,838 Cr₹8,067 Cr₹646 Cr₹60,924 Cr
     Job Work/ Contract Receipts ₹21 Cr₹3,421 Cr---
     Processing Charges / Service Income ₹49 Cr₹2,304 Cr₹3.46 Cr₹0.25 Cr₹16 Cr
     Revenue from property development -----
     Other Operational Income ----₹68 Cr
Less: Excise Duty -----
Net Sales ₹10,260 Cr₹874,943 Cr₹7,782 Cr₹621 Cr₹58,719 Cr
EXPENDITURE :
Increase/Decrease in Stock ₹-54 Cr₹29,074 Cr₹-450 Cr₹-25 Cr₹-105 Cr
Raw Material Consumed ₹3,252 Cr₹262,290 Cr₹2,871 Cr₹203 Cr₹18,885 Cr
     Opening Raw Materials ₹414 Cr₹39,862 Cr₹284 Cr₹25 Cr₹1,605 Cr
     Purchases Raw Materials ₹1,837 Cr₹182,940 Cr₹2,173 Cr₹141 Cr₹13,699 Cr
     Closing Raw Materials ₹409 Cr₹41,436 Cr₹399 Cr₹28 Cr₹2,331 Cr
     Other Direct Purchases / Brought in cost ₹1,410 Cr₹80,924 Cr₹814 Cr₹65 Cr₹5,912 Cr
     Other raw material cost -----
Power & Fuel Cost ₹125 Cr₹10,896 Cr₹103 Cr₹8.25 Cr₹800 Cr
     Electricity & Power ₹125 Cr₹10,896 Cr₹103 Cr₹8.25 Cr₹800 Cr
     Oil, Fuel & Natural gas -----
     Coals etc -----
     Other power & fuel -----
Employee Cost ₹2,261 Cr₹191,847 Cr₹1,621 Cr₹142 Cr₹13,355 Cr
     Salaries, Wages & Bonus ₹2,094 Cr₹178,801 Cr₹1,515 Cr₹133 Cr₹12,714 Cr
     Contributions to EPF & Pension Funds ₹100 Cr₹8,896 Cr₹74 Cr₹5.87 Cr₹429 Cr
     Workmen and Staff Welfare Expenses ₹19 Cr₹2,191 Cr₹15 Cr₹1.16 Cr₹89 Cr
     Other Employees Cost ₹47 Cr₹1,959 Cr₹17 Cr₹1.54 Cr₹123 Cr
Other Manufacturing Expenses ₹173 Cr₹15,057 Cr₹160 Cr₹14 Cr₹1,092 Cr
     Sub-contracted / Out sourced services -----
     Processing Charges -----
     Repairs and Maintenance ₹43 Cr₹3,887 Cr₹37 Cr₹2.70 Cr₹250 Cr
     Packing Material Consumed -----
     Other Mfg Exp ₹130 Cr₹11,170 Cr₹124 Cr₹11 Cr₹842 Cr
General and Administration Expenses ₹939 Cr₹100,080 Cr₹656 Cr₹45 Cr₹4,390 Cr
     Rent , Rates & Taxes ₹89 Cr₹13,196 Cr₹84 Cr₹5.86 Cr₹609 Cr
     Insurance ₹18 Cr₹1,544 Cr₹14 Cr₹1.04 Cr₹84 Cr
     Printing and stationery ₹9.50 Cr₹1,042 Cr₹7.02 Cr₹0.53 Cr₹43 Cr
     Professional and legal fees ₹203 Cr₹16,935 Cr₹88 Cr₹4.94 Cr₹308 Cr
     Traveling and conveyance ₹378 Cr₹49,605 Cr₹358 Cr₹27 Cr₹2,695 Cr
     Other Administration ₹242 Cr₹17,758 Cr₹105 Cr₹5.77 Cr₹651 Cr
Selling and Distribution Expenses ₹924 Cr₹63,811 Cr₹708 Cr₹59 Cr₹4,267 Cr
     Advertisement & Sales Promotion ₹601 Cr₹37,367 Cr₹452 Cr₹39 Cr₹2,553 Cr
     Sales Commissions & Incentives ₹198 Cr₹18,049 Cr₹174 Cr₹14 Cr₹1,244 Cr
     Freight and Forwarding ₹125 Cr₹8,367 Cr₹82 Cr₹6.15 Cr₹470 Cr
     Handling and Clearing Charges -----
     Other Selling Expenses ₹0.15 Cr₹28 Cr₹0.22 Cr₹0.02 Cr-
Miscellaneous Expenses ₹125 Cr₹11,696 Cr₹121 Cr₹11 Cr₹1,587 Cr
     Bad debts /advances written off ₹4.62 Cr₹464 Cr₹4.92 Cr₹0.06 Cr₹6.12 Cr
     Provision for doubtful debts ₹7.96 Cr₹915 Cr₹9.65 Cr₹0.11 Cr₹59 Cr
     Losson disposal of fixed assets(net) --₹3.74 Cr₹0.30 Cr-
     Losson foreign exchange fluctuations ----₹10 Cr
     Losson sale of non-trade current investments -----
     Other Miscellaneous Expenses ₹112 Cr₹10,317 Cr₹103 Cr₹10 Cr₹1,511 Cr
Less: Expenses Capitalised -----
Total Expenditure ₹7,745 Cr₹684,750 Cr₹5,791 Cr₹457 Cr₹44,272 Cr
Operating Profit (Excl OI) ₹2,515 Cr₹190,193 Cr₹1,991 Cr₹165 Cr₹14,447 Cr
Other Income ₹280 Cr₹12,857 Cr₹196 Cr₹17 Cr₹1,038 Cr
     Interest Received ₹40 Cr₹1,276 Cr₹13 Cr₹3.83 Cr₹129 Cr
     Dividend Received -₹0.24 Cr₹0.00 Cr₹0.04 Cr₹43 Cr
     Profit on sale of Fixed Assets ₹0.48 Cr₹166 Cr--₹19 Cr
     Profits on sale of Investments ----₹351 Cr
     Provision Written Back ₹2.48 Cr₹415 Cr₹34 Cr₹0.77 Cr-
     Foreign Exchange Gains ₹8.44 Cr₹1,041 Cr₹8.85 Cr₹0.05 Cr-
     Others ₹229 Cr₹9,958 Cr₹140 Cr₹12 Cr₹496 Cr
Operating Profit ₹2,795 Cr₹203,050 Cr₹2,187 Cr₹182 Cr₹15,485 Cr
Interest ₹34 Cr₹4,576 Cr₹60 Cr₹2.12 Cr₹232 Cr
     InterestonDebenture / Bonds -----
     Interest on Term Loan ₹19 Cr₹3,605 Cr₹16 Cr₹1.55 Cr₹137 Cr
     Intereston Fixed deposits -----
     Bank Charges etc ₹6.42 Cr₹130 Cr₹4.02 Cr₹0.19 Cr₹17 Cr
     Other Interest ₹8.71 Cr₹842 Cr₹40 Cr₹0.38 Cr₹78 Cr
PBDT ₹2,761 Cr₹198,473 Cr₹2,127 Cr₹180 Cr₹15,253 Cr
Depreciation ₹378 Cr₹32,592 Cr₹167 Cr₹12 Cr₹991 Cr
Profit Before Taxation & Exceptional Items ₹2,383 Cr₹165,881 Cr₹1,960 Cr₹168 Cr₹14,262 Cr
Exceptional Income / Expenses -----
Profit Before Tax ₹2,398 Cr₹167,124 Cr₹1,975 Cr₹169 Cr₹14,377 Cr
Provision for Tax ₹457 Cr₹36,156 Cr₹522 Cr₹40 Cr₹3,816 Cr
     Current Income Tax ₹495 Cr₹33,199 Cr₹451 Cr₹39 Cr₹4,084 Cr
     Deferred Tax ₹-31 Cr₹4,117 Cr₹49 Cr₹0.24 Cr₹-327 Cr
     Other taxes ₹-7.22 Cr₹-1,160 Cr₹21 Cr₹0.14 Cr₹59 Cr
Profit After Tax ₹1,941 Cr₹130,968 Cr₹1,453 Cr₹129 Cr₹10,561 Cr
Extra items ₹0.98 Cr----
Minority Interest ₹-29 Cr₹-2,782 Cr₹-19 Cr₹-2.76 Cr₹-257 Cr
Share of Associate -----
Other Consolidated Items -----
Consolidated Net Profit ₹1,913 Cr₹128,186 Cr₹1,433 Cr₹127 Cr₹10,304 Cr
Adjustments to PAT -----
Profit Balance B/F ₹8,012 Cr₹673,519 Cr₹5,304 Cr₹407 Cr₹34,076 Cr
Appropriations ₹9,925 Cr₹801,705 Cr₹6,737 Cr₹533 Cr₹44,380 Cr
     General Reserves -----
     Proposed Equity Dividend -----
     Corporate dividend tax -----
     Other Appropriation ₹6.27 Cr₹485 Cr₹1.80 Cr₹2.74 Cr₹2,484 Cr
Equity Dividend % ----₹310.00
Earnings Per Share ₹47.75₹32.00₹35.78₹31.59₹25.72
Adjusted EPS ₹47.75₹32.00₹35.78₹31.59₹25.72

Compare Income Statement of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹105,786.2 Cr -0.2% -1.7% 6.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,368.0 Cr 0.7% -0.7% -11% Stock Analytics
DIVIS LABORATORIES ₹160,631.0 Cr NA -1.6% 12.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,641.0 Cr 3.1% -0.9% 9.1% Stock Analytics
CIPLA ₹123,419.0 Cr -2% -4% -5.9% Stock Analytics
DR REDDYS LABORATORIES ₹109,176.0 Cr -0.2% 2.4% 0% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.2%

-1.7%

6.8%

SENSEX

-0.3%

0.1%

-1%


You may also like the below Video Courses